Synergy Pharmaceuticals – SGYP – Acquires FV-100 Shingles Drug From Bristol-Myers Squibb Company
Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has signed an Asset Purchase Agreement with Bristol-Myers Squibb Company (NYSE:BMY) and has acquired the assets related to...